论文部分内容阅读
目前,全球约有20亿乙型肝炎患者,而大约有3.5亿患者为慢性疾病[1-2]。在中国,约有1.2亿乙型肝炎患者。乙型肝炎病毒长期进行复制是慢性乙肝患者出现肝脏炎症,同时是造成肝硬化、肝癌等疾病出现的重要影响因素。国内外研究表明,人体内部的DNA载量与肝脏出现病变的严重情况具有正相关性[3-4]。因此,抗病毒方式进行治疗是乙型肝炎患者的关键之处,可以发挥长期防止乙型肝炎病毒出现复制,防
Currently, there are about 2 billion hepatitis B patients worldwide, while about 350 million patients are chronic diseases [1-2]. In China, there are about 120 million hepatitis B patients. Long-term replication of hepatitis B is a chronic hepatitis B patients with liver inflammation, is also an important factor in causing cirrhosis, liver cancer and other diseases appear. Domestic and foreign studies have shown that there is a positive correlation between the DNA load in the human body and the severity of the lesions in the liver [3-4]. Therefore, anti-virus treatment is the key to hepatitis B patients can play a long-term prevention of hepatitis B virus replication, prevention